EDGAR Filing Documents for 0001104659-15-084788

Form 8-K - Current report:

SEC Accession No. 0001104659-15-084788

Filing Date

2015-12-15

Accepted

2015-12-15 07:40:43

Documents

Period of Report

2015-12-15

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a15-25001_18k.htm	8-K	33060
2	EX-99.1	a15-25001_1ex99d1.htm	EX-99.1	26700
3	EX-99.2	a15-25001_1ex99d2.htm	EX-99.2	72892
4	EX-99.3	a15-25001_1ex99d3.htm	EX-99.3	258184
5	EX-99.4	a15-25001_1ex99d4.htm	EX-99.4	24702
6	GRAPHIC	g250011msi001.gif	GRAPHIC	3506
7	GRAPHIC	g250011mq05i001.jpg	GRAPHIC	3702
8	GRAPHIC	g250011mq05i002.gif	GRAPHIC	14472
9	GRAPHIC	g250011mq05i003.jpg	GRAPHIC	3321
10	GRAPHIC	g250011mmi001.gif	GRAPHIC	3780
	Complete submission text file	0001104659-15-084788.txt		457158

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054

Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560

Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 151287317
SIC: 2834 Pharmaceutical Preparations